The endoplasmic reticulum (ER) contains a number of thiol-disulfide oxidoreductases of the protein-disulfide isomerase (PDI) family that catalyze the formation of disulfide bonds in newly synthesized proteins. Here we describe the identification and characterization of a novel member of the human PDI family, TMX3 (thioredoxin-related transmembrane protein 3). The TMX3 gene encodes a protein of 454 amino acid residues that contains a predicted N-terminal signal sequence, a single domain with sequence similarity to thioredoxin and a CGHC active site sequence, a potential transmembrane domain, and a C-terminal KKKD tetrapeptide sequence that matches the classical KKXX-type consensus sequence for ER retrieval of type I transmembrane proteins. Endogenous TMX3 contains endoglycosidase Hsensitive glycans, localizes to the ER by immunofluorescence microscopy, and is present in the membrane fraction after alkaline extraction of the ER luminal content. The TMX3 transcript is found in a variety of tissues and is not up-regulated by the unfolded protein response. Circular dichroism spectroscopy of the recombinantly expressed luminal domain of TMX3 showed features typical of a properly folded protein of the ␣/␤ type. The redox potential of recombinant luminal TMX3 was determined to ؊0.157 V, similar to the values previously found for PDI and ERp57. Interestingly, TMX3 showed oxidase activity, and in human tissue-culture cells the protein was found partially in the oxidized form, potentially suggesting a function of the protein as a dithiol oxidase.
The formation of disulfide bonds plays a critical role for the correct folding of most secretory and plasma membrane proteins in the endoplasmic reticulum (ER). 1 Whereas folding of certain proteins proceeds by the sequential formation of native disulfides, it is clear that other proteins (e.g. the low density lipoprotein receptor) (1) form long range nonnative disulfides that are later rearranged as an integral folding step in living cells. Both the formation and the rearrangement of disulfide bonds often rely on the catalysis by thiol-disulfide oxidoreductases.
Protein-disulfide isomerase (PDI) is the founding member of a family of thiol-disulfide oxidoreductases in the ER (reviewed in Ref. 2) . The protein contains four domains, named a, b, b, and a, all with homology to thioredoxin. Like this cytosolic reductase, the catalytic a and a domains of PDI contain tetrapeptide CXXC active site sequences (where X denotes any amino acid), for catalysis of thiol-disulfide exchange reactions. These reactions proceed through transient mixed disulfide intermediates between enzyme and substrate and lead to the oxidation (formation), reduction (breaking), or isomerization (rearrangement) of substrate cysteines. The two active site cysteines in oxidoreductases are found either in the oxidized disulfide or the reduced dithiol form; the disulfide form determines the function of the enzyme as an oxidase, whereas the dithiol form allows it to act as a reductase and/or an isomerase. Of the noncatalytic PDI b and b domains that both lack active site cysteines, PDI b is capable of interacting directly with the polypeptide chain of substrate proteins (3, 4) , whereas the function of the b domain is less well understood.
The need to catalyze both oxidation and reduction in the same compartment poses a regulatory problem. In the periplasm of Escherichia coli, where both types of reactions also take place, the pathways for oxidation and reduction are segregated as a result of unfavorable kinetics for the interaction between proteins in different pathways (5) . In the ER, work on the Ero1 flavoprotein has revealed that it functions as a thiol oxidase for PDI. In this pathway, substrate protein oxidation by PDI reduces its active site disulfide. The two electrons accepted by PDI in this process are transferred to Ero1 and further on to molecular oxygen (6 -10) . In itself, the reduction of molecular oxygen by this pathway holds the potential to generate significant amounts of reactive oxygen species (11) . Indeed, recent work has elegantly demonstrated a direct connection between oxidative folding in the ER, Ero1 expression levels, and reactive oxygen species production (12, 13) .
With respect to a reductive pathway, the glutathione redox buffer probably plays a significant role. The redox environment in the ER is relatively more oxidizing than in the cytosol, and the abundant presence of protein-glutathione mixed disulfides has suggested a mechanism of disulfide-bond formation involving oxidized glutathione (GSSG) (14) . Still, there is an approximately 3-fold excess of reduced (GSH) over oxidized glutathione in the ER (14, 15) , and most recent work in the field has been focused on the function of GSH. For instance, decreasing the ER luminal level of GSH has been found to promote protein misfolding through the formation of nonnative disulfides (16, 17) . Furthermore, ER overexpression of a misfolded disulfidecontaining protein leads to the increased production of GSSG at the expense of GSH, implying a role for GSH in directly resolving wrongly formed disulfides (13) . By maintaining active site cysteines of ER thiol-disulfide oxidoreductases in the reduced form, GSH could also function to determine the activity of these enzymes as reductases or isomerases (18) . Altogether, current findings highlight a role of GSH in providing reducing equivalents to balance the oxidative power of the PDI-Ero1 pathway. No protein-associated disulfide reductase activity has been identified in the ER to date.
Whereas the function of PDI is relatively well characterized, with the factors regulating pathways for oxidation and reduction in the ER gradually being worked out, basic questions relating to the function of many human ER thiol-disulfide oxidoreductases remain open. The human PDI family consists of close to 20 proteins, all comprising at least one (catalytic or noncatalytic) thioredoxin-like domain (19) . Several of these proteins, such as ERp18 (ERp19) (20, 21) , ERp44 (22, 23) , ERp46 (EndoPDI) (21, 24) , ERdj5 (25, 26) , and PDILT (27) , have been identified within the past 2 years. Little is known about the redox function performed by PDI family members in vivo. For instance, PDI is the only Ero1 substrate identified in higher eukaryotes. Whereas PDI interacts with a broad range of substrates, and its close homologue ERp57 functions as an oxidoreductase for newly synthesized glycoproteins (28, 29) , very few endogenous substrates have been identified for other PDI family members. A key to improving our understanding of ER redox processes will be a better characterization of these proteins. Thereby, we are also likely to learn more about the underlying causes of some of the human diseases that arise due to protein misfolding in the ER (e.g. see Ref. 30 and references therein). Here we describe the characterization of a new human protein of the PDI family, TMX3.
MATERIALS AND METHODS
Cells and Antibodies-Human embryonic kidney (HEK293) and Vero cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal calf serum (LabForce AG) and 1% nonessential amino acids, and HeLa cells were cultured in ␣-minimal essential medium (Invitrogen) with 10% fetal calf serum. The polyclonal anti-TMX3-C anti-peptide serum against TMX3 was generated by Eurogentec (Seraing, Belgium) by immunizing rabbits with a peptide corresponding to the 15 C-terminal residues (PTVQEPKDVLEKKKD) of the protein coupled via an N-terminal cysteine to keyhole limpet hemocyanin. Subsequently, the antiserum was affinity-purified against the antigenic peptide. The HA.11 mouse monoclonal antibody specific for the HA epitope was from Covance (Richmond, CA), Alexa-red goat anti-mouse IgG was from Molecular Probes (Leiden, The Netherlands), and the SPA-600 rabbit polyclonal antiserum against calreticulin was from Stressgen (Victoria, Canada). The polyclonal rabbit antiserum against calnexin was generously provided by Dr. A. Helenius (ETH Zü rich).
Plasmids and Vectors-The TMX3 cDNA clone hj01608 (KIAA1830 protein) was obtained from Kazusa DNA Research Institute (Chiba, Japan). An HA-tagged version of TMX3 was made by inserting the sequence encoding an HA tag flanked by NheI sites immediately prior to the C-terminal KKKD sequence. Including the residues encoding the two NheI sites, the C-terminal sequence of this construct is as follows: ASYPYDVPDYASKKKD. This construct was generated by PCR using the TMX3 cDNA clone as a template, together with the 1-BAB4 -3 (5Ј-AGGCAGCTGCGGCCGCAGCATGGCAGCGTGGAA-3Ј) and 2-BA-B4HA-5 (5Ј-GTTCTAGACTAGTCCTTTTTCTTGCTAGCGTAGTCTG-GGACGTCGTATGGGTAGCTAGCTTCTAATACATCCTTGGGCTC-3Ј) primers. The PCR product was inserted into the pcDNA3 vector (Stratagene, La Jolla, CA) using NotI and XbaI restriction sites to yield the pcDNA3/TMX3-HA expression plasmid. For expression of the ER luminal region of TMX3 (TMX3lum, residues 25-373; all TMX residue numbers in this study refer to the human sequence including the predicted signal peptide, accession number NP_061895) in E. coli, a PCR was performed using the TMX3 cDNA clone as a template, together with the 3-BAB4-Trx-3 (5Ј-GGGGGATCCAAAGGATTTGTAGAAGAT-TTAG-3Ј) and 26-BAB4-lum-5 (5Ј-CCGGAATTCCTAGCTCTTGAATA-TAGACACAATAGTAG-3Ј) primers. The PCR product was inserted into a pRSETA-derived E. coli expression vector (pRSET-miniT) (31) using BamHI and EcoRI restriction sites to yield the pRSET-miniT/TMX3lum vector. This construct was used to express the luminal part of TMX3 devoid of its ER signal peptide but with a 17-amino acid N-terminal affinity tag including six histidines and a thrombin cleavage site. After thrombin cleavage, a GS dipeptide sequence remains at the N terminus of the TMX3 construct. The sequence of all generated plasmids was verified by DNA sequencing.
Protein Expression and Purification-pRSET-miniT/TMX3lum was transformed into the Rosetta(DE3) E. coli strain (Novagen, San Diego, CA) and plated on LB-agar containing 100 g/ml ampicillin and 34 g/ml chloramphenicol. From a fresh transformation, all colonies were dissolved in LB medium to inoculate a 500-ml preculture that was grown at 37°C for 2 h in LB medium containing antibiotics as described above. 100 ml of the preculture was then used to inoculate 1 liter of fresh LB medium with antibiotics and was grown in an orbital shaker at 230 rpm until an A 600 of 0.75 was reached. The expression of His 6 -TMX3lum was induced with 1 mM isopropyl ␤-D-1-thiogalactopyranoside, and the culture was grown for an additional 3 h at 37°C before the cells were harvested by centrifugation. Cell pellets were resuspended in buffer A (6 M guanidine hydrochloride, 100 mM NaCl, 25 mM Tris-HCl, pH 8.0, 5 mM 2-mercaptoethanol), sonicated, and subjected to centrifugation for 1 h at 30,000 ϫ g. The clear supernatant was applied to an Ni 2ϩ -charged nitrilotriacetic acid metal affinity chromatography column (Qiagen) and equilibrated with buffer B (6 M guanidine hydrochloride, 1 M NaCl, 25 mM Tris-HCl, pH 8.0, 5 mM 2-mercaptoethanol). After loading and washing with at least 5 column volumes of buffer B, the protein was refolded while bound on the column using a linear gradient over 25 column volumes from buffer B into buffer C (20 mM sodium phosphate buffer, pH 7.4, 25 mM NaCl, 1 mM 2-mercaptoethanol). Subsequently, the refolded protein was eluted with a linear gradient over 10 column volumes into buffer C containing 500 mM imidazol. Fractions containing TMX3lum were pooled and cleaved with thrombin (Sigma) using 2.5 units/mg protein for 3 h at room temperature, before dialysis into buffer D (25 mM NaCl, 25 mM Tris-HCl, 1 mM dithio-1,4-threitol (DTT)). Finally, the protein was loaded on to a SOURCE15Q anion exchange chromatography column (Amersham Biosciences) preequilibrated in buffer D and eluted with a gradient over 20 column volumes against buffer D containing 500 mM NaCl. In this gradient, TMX3lum eluted at ϳ250 mM NaCl.
Protein Concentration Determination-The concentration of the purified TMX3lum protein was determined from its absorbance at 280 nm by using the molar extinction coefficients calculated by the method of Gill and von Hippel (32) . An extinction coefficient of 45,800 M Ϫ1 cm
Ϫ1
was used for TMX3lum. Circular Dichroism Measurements-CD measurements were performed on a Jasco J-810 spectropolarimeter in a 1-mm path length cell at 25°C. Spectra were averaged from 10 scans, and the buffer base line was subtracted. TMX3lum was used at a concentration of 10 M in a buffer containing 50 mM KH 2 PO 4 /KOH, pH 7.0. The protein was reduced with 2 mM DTT and oxidized with 0.1 mM GSSG. Reduction and oxidation were performed by dialyzing against the respective buffers overnight.
Fluorescence Spectroscopy-Fluorescence experiments were performed at 25°C on a Varian Cary Eclipse spectrofluorometer, with samples preequilibrated to the same temperature. The scan rate was set to 300 nm/min, excitation and emission slits were set to 5 nm, and a total of five scans were averaged for each measurement. After excitation at either 280 or 295 nm, an emission scan was recorded between 300 and 400 nm. All spectra of TMX3lum (at 1-2 M concentration) were recorded in a buffer containing 100 mM KH 2 PO 4 /KOH, pH 7.0, and 1 mM EDTA with or without 6.0 M guanidine hydrochloride that had been filtered, degassed, and flushed with N 2 prior to use. The completely reduced protein was measured at 10 mM GSH or 2 mM DTT, and the completely oxidized protein was measured at 0.1 mM GSSG.
Redox Equilibrium between TMX3lum and Glutathione-Equilibration of the TMX3lum protein at different GSH/GSSG ratios in 100 mM KH 2 PO 4 /KOH, 1 mM EDTA pH 7.0 was performed for at least 16 h under an N 2 atmosphere. A protein concentration of 1 M was used in all experiments. After excitation at 280 or 295 nm, the fluorescence intensity at 327 nm, the wavelength at which the maximal difference between the emission of oxidized and reduced protein was observed, was recorded for 20 s and averaged. To determine the equilibrium constant K eq for the TMX3lum/glutathione system, the fluorescence emission at [GSH] 2 /[GSSG] ratios from 2.4 ϫ 10 Ϫ6 to 1 M was measured. This was achieved by varying the GSH concentration between 0.015 and 10 mM at a constant GSSG concentration of 0.1 mM. The completely reduced protein was measured at 10 mM GSH, and the completely oxidized protein was measured at 0.1 mM GSSG. The measured fluorescence F was plotted against the [GSH] 2 /[GSSG] ratio and fitted according to Equation 1 to obtain F ox , the fluorescence of oxidized protein, and F red , the fluorescence of reduced protein. The relative amount of reduced protein at equilibrium (R), determined with Equa-tion 2, was plotted against the [GSH] 2 /[GSSG] ratio, and the data were fitted according to Equation 1 to obtain K eq . The equilibrium redox potential of the TMX3lum protein was then calculated with the Nernst equation (Equation 3) using the glutathione standard potential EЈ 0(GSH/GSSG) of Ϫ0.240 V at pH 7.0 and 25°C (33) .
Oxidase Assay-The oxidase activity of TMX3lum was monitored using the decapeptide NRCSQGSCWN originally described by Ruddock et al. (34) . The assay was performed in a volume of 1 ml in 100 mM KH 2 PO 4 /KOH, pH 7.0, 2 mM EDTA, 2 mM GSH, 0.5 mM GSSG, with or without 0.2 M protein catalyst. First, the reaction mix without the peptide substrate was placed in a Varian Cary Eclipse spectrofluorometer for 300 s to allow thermal equilibration of the solution to 25°C. Then the reduced substrate peptide (0.407 mM, in 30% acetonitrile/0.1% trifluoroacetic acid) was added to a concentration of 3.4 M and mixed, and the change in fluorescence (excitation at 280 nm, emission at 350 nm) was monitored over an appropriate time, with 1 data point collected/s. Upon oxidation, the intrinsic tryptophan fluorescence of the peptide decreases to 81% of the value of the reduced peptide (34) . The determination of the half-time for oxidation was performed as described in Ref. 34 . The human recombinant PDI used in this assay was expressed and purified as described previously (35) .
Northern Blotting of RNA from Human Tissues-The human multiple tissue Northern (MTN) blot (Clontech, Palo Alto, CA) was hybridized with a 671-base pair fragment derived from TMX3 cDNA by digestion with SacI. The gel-purified fragment was labeled with [␣-32 P]dCTP using the Rediprime II Random Prime Labeling System (Amersham Biosciences), followed by purification using a Bio-Spin6 column (BioRad) to remove unincorporated nucleotides. Hybridization was done at 65°C in ExpressHyb buffer (Clontech), following the manufacturer's protocol. For visualization, the probed MTN blots were subjected to autoradiography.
Unfolded Protein Response (UPR) Analysis-To induce the UPR, HEK293 cells were cultured for 6 h in the presence of tunicamycin (10 g/ml) or DTT (2 mM), whereas stress not inducing the UPR was generated by incubating cells for 30 min at 42°C. Total RNA was isolated from cells with the TRI Reagent (Molecular Research Center, Cincinnati, OH) following the supplier's protocol. Approximately 7.5 g of extracted total RNA in 5 l of H 2 O were diluted in 25 l of freshly prepared RNA loading buffer (1.1ϫ MOPS, pH 7.0, 11 M formamide, 2.2 M formaldehyde, 70 g/ml ethidium bromide, 5% glycerol, 0.6‰ bromphenol blue) and electrophoretically resolved on an agarose-formaldehyde gel (1ϫ MOPS, 2 M formaldehyde, 1% agarose). Following electrophoresis, the gel was washed in H 2 O and soaked for 45 min in 10 gel volumes of 10ϫ SSC buffer. The RNA gel was blotted overnight in 10ϫ SSC buffer through capillary force onto a Zeta-Probe membrane (BioRad), which was subsequently fixed by baking at 80°C for 30 min. The membrane was hybridized sequentially with specific probes for TMX3 as described above, and with a 651-base pair fragment derived from a BiP hamster cDNA (kindly provided by R. Sitia, Milan) by digestion with EcoRI and BsrGI. Hybridization was done overnight at 65°C in 10% dextran sulfate (molecular weight 500,000 g/mol), 1 M NaCl, 0.8% SDS. Blots were quickly washed twice in 6ϫ SSC, 1% SDS at 60°C, followed by two washing steps for 30 min at 60°C in 2ϫ SSC, 0.1% SDS and once for 20 min in 0.2ϫ SSC, 0.1% SDS. Finally, the membrane was rinsed in 0.2ϫ SSC and subjected to autoradiography. Bands were quantified using ImageQuant Version 1.2 (Amersham Biosciences).
Gel Electrophoresis and Western Blotting-All samples for Western blotting were first separated on 10 ϫ 10.5-cm Hoeffer minigels, 7.5% SDS-polyacrylamide gels before transfer onto a polyvinylidene difluoride membrane. Blots were probed with the affinity-purified anti-TMX3-C antiserum at a dilution of 1:500 as a primary antibody, followed by the addition of the horseradish peroxidase-coupled goat antirabbit IgG (Pierce) secondary antibody used at a dilution of 1:50,000. Bound antibody was detected with the ECL plus Western blotting Detection System (Amersham Biosciences).
Cell Fractionation and Alkaline Extraction-Tissue culture dishes (100 mm) of 80% confluent HeLa cells were washed twice and scraped into PBS. Cells collected from one dish were pelleted at 300 ϫ g for 5 min at 4°C, before swelling in 500 l of buffer A (10 mM HEPES-KOH, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT) for 10 min at 4°C. After centrifugation at 300 ϫ g for 5 min, the pellet was resuspended in 500 l of buffer A and homogenized by passage 10 times through a 0.5-mm gauge needle. Unbroken cells and nuclei were removed by centrifugation at 1,000 ϫ g for 10 min at 4°C. Crude membranes were obtained by centrifugation of the postnuclear supernatant at 100,000 ϫ g for 15 min at 4°C. Next, the pellet was subjected to alkaline extraction with 100 mM Na 2 CO 3 (pH 11.3) for 30 min on ice. Before the following ultracentrifugation step, a sample was removed, representing the total extract. Ultracentrifugation at 130,000 ϫ g for 15 min at 4°C through a sucrose cushion was used to separate soluble from insoluble material. The supernatant, representing the soluble fraction, was removed, and the pellet was extracted a second time with Na 2 CO 3 as above and centrifuged through a sucrose cushion once again, to yield the insoluble fraction. Both supernatant and pellet were then delipidated by the addition of acetone to 25% followed by precipitation with 15% trichloroacetic acid. After centrifugation at 14,000 ϫ g for 5 min at 4°C, the pellet was washed with acetone, dried, and resuspended in SDS-PAGE sample buffer. The resulting samples were subjected to SDS-PAGE followed by Western blot analysis as described above.
Endoglycosidase H Digestion-To investigate the glycosylation status of TMX3, HeLa cells were first lysed in 180 mM Tris-HCl, pH 6.8, 0.5% SDS, and 1% 2-mercaptoethanol. The lysate was then denatured at 100°C for 10 min, supplemented with one-tenth volume of 50 mm sodium citrate, pH 5.5, and treated with endoglycosidase H (New England Biolabs, Beverly, MA) at 37°C for 1 h using 25 units/cm 2 of confluent HeLa cells used for the sample preparation. The resulting samples were subjected to SDS-PAGE followed by Western blot analysis as described above.
Immunofluorescence-The subcellular localization of TMX3 in Vero cells was analyzed by immunofluorescence microscopy, using colocalization with an ER-localized GFP variant containing an ER retention signal as an ER marker. Vero cells were co-transfected with pcDNA3/TMX3-HA and pCMV/Myc/ER/GFP (Invitrogen) using an AMAXA electroporator, following the manufacturer's protocol as suggested for Vero cells. Transfected cells on microscope coverslips were fixed 16 h post-transfection by using the method of McLean and Nakane (36) . In brief, cells were incubated for 2 h in fixing solution (10 mM sodium periodate, 75 mM lysine, 375 mM sodium phosphate, pH 6.2, 2% paraformaldehyde). The fixed cells were washed with PBS ϩϩ and permeabilized with a solution of 15 mM glycine, 0.05% saponin, 10 mM HEPES, and 10% goat serum in PBS ϩϩ for 15 min at room temperature. Next, cells were incubated with the monoclonal HA.11 antibody directed against the HA epitope, diluted 1:500 in permeabilization solution. After incubation for 1 h at room temperature, the cells were washed in permeabilization solution, followed by incubation for 1 h with an Alexa-red goat anti-mouse antibody diluted 1:200 in permeabilization solution. Coverslips were washed with permeabilization solution, briefly rinsed with water, and mounted on slides with Moviol. Confocal images of fixed cells were acquired with an inverted Zeiss LSM 510 metamicroscope (apochrome 100ϫ objective, numerical aperture 1.4).
Determination of the in Vitro Redox State-The oxidation state of TMX3lum upon equilibration in different glutathione buffers was investigated by a gel shift assay after modification with 4-acetamido-4-maleimidylstilbene-2,2-disulfonic acid (AMS). For this purpose, the samples were precipitated with 10% trichloroacetic acid. Pellets were washed with acetone and resuspended in 80 mM Tris-HCl, pH 6.8, 2% SDS, 10 mM AMS, followed by incubation for 30 min at 25°C and an additional 10 min at 37°C. After AMS treatment, samples were separated by nonreducing SDS-PAGE, and gels were stained with Coomassie Blue.
Determination of the in Vivo Redox State-HeLa or HEK293 cells were incubated in the appropriate medium with or without 10 mM DTT or 5 mM N,N,NЈ,NЈ-tetramethylazodicarboxamide (diamide) for 5 min at 37°C. The medium was removed, and the cells were briefly washed with ice-cold PBS and lysed for 5 min at 0°C in 2% SDS in 20% formic acid. Cell lysates were precipitated with 10% trichloroacetic acid by incubating 10 min on ice followed by centrifugation for 15 min at 14,000 ϫ g at 4°C. Precipitates were washed twice with ice-cold 70% acetone. After centrifugation, the pellets were resuspended in 80 mM Tris-HCl, pH 6.8, 2% SDS, 1 mM phenylmethylsulfonyl fluoride with or without 10 mM AMS. Subsequently, samples were incubated for 30 min at room temperature and for an additional 10 min at 37°C. Finally, samples were subjected to nonreducing SDS-PAGE followed by Western blot analysis as described above. In an alternative protocol, we used the membrane-permeable thiol-modifying agent N-ethylmaleimide (NEM) to block free cysteines. After incubation in medium with or without DTT (10 mM) or diamide (5 mM), cells were briefly washed and incubated in
fluoride, 20 mM NEM for 20 min on ice and were then treated with 50 mM DTT for 15 min at 50°C. Finally, cell lysates were trichloroacetic acid-precipitated and treated with or without AMS as described above.
RESULTS
Sequence Characteristics of the TMX3 Protein-Using a consensus sequence for a thioredoxin-like domain as query sequence, we identified a previously uncharacterized open reading frame (RefSeq: NM_019022.3) by BLAST searching at the NCBI Web interface. The N-terminal 24 amino acid residues of the human protein sequence are predicted to constitute an ER signal peptide (Fig. 1) , using the combined transmembrane topology and signal peptide predictor Phobius (37). After cleavage of the signal peptide, the mature protein comprises 430 residues and has a calculated molecular mass of 49.2 kDa with a theoretical pI of 4.7. Phobius also predicted a single transmembrane region (residues 375-397; residue numbering including the signal peptide) and thereby a C-terminal cytosolic tail of 57 residues with a classical KKXX-type sequence for ER retrieval of type I transmembrane proteins at the C terminus. Based on the presence of a thioredoxin-like domain and a transmembrane region, we named the protein TMX3 (thioredoxin-related transmembrane protein 3).
The single catalytic thioredoxin-like domain in TMX3 is found at the very N terminus of the mature protein (Fig. 1) . It shows 40% sequence identity to the PDI a domain and contains no insertions or deletions relative to this domain. The active site sequence, CGHC, is the most common among ER proteins of the PDI family. Two additional cysteines are found in the sequence of the mature protein, but since they are both located in the predicted transmembrane region, they are not expected to have a direct role in catalysis of disulfide exchange reactions. The remaining two-thirds of the luminal domain show weak sequence similarity to calsequestrin, an important calciumbinding protein of the sarcoplasmic reticulum, and no homology to catalytic inactive thioredoxin-like domains of the b or b type found in PDI and other oxidoreductases of the ER. Still, secondary structure predictions performed using a number of different tools at the PredictProtein server (38) show that this region of the protein is likely to contain two additional domains with a thioredoxin fold.
Homologues of TMX3 are found in a number of vertebrates, urochordates, arthropods, and nematodes but not in fungi or lower organisms. A multiple sequence alignment of the TMX3 protein from humans, mice, Drosophila melanogaster, and Caenorhabditis elegans shows that the catalytic thioredoxin-like domain constitutes the most conserved region (Fig. 1B) . The overall sequence identity with the mature human protein is 93% for the mouse protein, 28% for the D. melanogaster protein, and 28% for the C. elegans protein.
Tissue Expression Pattern and Regulation of the TMX3 Transcript-The gene encoding human TMX3 localizes to chromosome 18 q22.1 and is predicted to contain 16 exons and to cover 41.44 kb of genomic DNA. The transcript length is predicted to 4.8 kb excluding the poly(A) tail. However, the polyadq program for prediction of human polyadenylation signals (39) predicted a second poly(A) signal at 3.7 kb (Fig. 2A) . A combination of publicly available data in the Unigene, SAGEmap, and expressed sequence tag data bases (40) shows that transcripts of TMX3 are expressed in a variety of human tissues including brain, testis, lung, skin, kidney, uterus, bone, stomach, liver, prostate, placenta, eye, and muscle. Using a probe derived from the TMX3 cDNA clone hj01608 obtained from the Kazusa DNA Research Institute, we next verified the presence of the TMX3 transcript in eight different human tissues and found the highest levels in heart and skeletal muscle (Fig. 2B) . Two transcripts at ϳ5.1 and ϳ4.0 kb were detected, potentially arising from alternative splicing or from use of the two different poly(A) signals.
Cellular stress that leads to the accumulation of misfolded proteins in the ER results in a transcriptional and translational response known as the unfolded protein response (UPR) (41) . Among other things, the UPR up-regulates the transcription of a number of ER-resident chaperones and redox enzymes, such as BiP, Ero1␤, and PDI. To test if the TMX3 transcript was up-regulated by stress conditions that induce the UPR, we treated HEK293 cells with tunicamycin and DTT, both drugs known to cause accumulation of misfolded proteins in the ER. Still, under these experimental conditions, we did not observe any increase in TMX3 transcription levels when compared with nonstressed HEK293 cells, whereas the positive control transcript, BiP, was up-regulated 13-and 6-fold by tunicamycin and DTT treatment, respectively (Fig. 2C) . The amount of rRNA on the agarose-formaldehyde gel (Fig. 2C, top  panel) was used for normalization. Similar results were obtained in HeLa cells (data not shown).
TMX3 Is a Membrane-associated Protein of the ER-
The sequence analysis of TMX3 showed that it is potentially a type I transmembrane protein of the ER. The combination of three lines of experimental evidence supported this prediction.
TMX3 has two NX(S/T) consensus sites for N-linked glycosylation in the ER luminal region (Fig. 1) . By Western blot analysis of HeLa cell lysates, we tested whether the protein contained N-glycans sensitive to treatment with endoglycosidase H. This enzyme removes the high mannose type N-glycans typical of glycoproteins in the ER but does not hydrolyze complex glycans generated by modification in the Golgi. For Western blotting, we used a newly generated and affinity-purified anti-TMX3 rabbit antiserum raised against a C-terminal peptide of the protein (see "Materials and Methods"). The polyclonal anti-TMX3 antibody, anti-TMX3-C, recognized a single band running at ϳ61 kDa (Fig. 3A) , whereas the preimmune serum showed no reaction (data not shown). This is in good agreement with the predicted molecular mass of ϳ55 kDa for TMX3 containing two N-glycans. A slightly slower than expected migration by SDS-PAGE has been observed for other ER proteins with a low pI value, such as calnexin and calreticulin. When transiently transfecting HeLa cells with the pcDNA3/TMX3-HA construct, the HA-tagged protein runs slightly above the 61-kDa band of the endogenous protein due to the presence of the epitope tag and was not recognized by the anti-TMX3-C antibody (data not shown). Since the HA tag was inserted in the middle of the peptide used to generate the anti-TMX3-C antibody, this finding strongly supported that the protein recognized by anti-TMX3-C indeed represents endogenous human TMX3. Upon treatment of HeLa cell lysates with endoglycosidase H, the band representing TMX3 showed increased mobility in the gel compared with a mock-treated sample (Fig. 3A) . Judging from the size of the mobility shift, we concluded that TMX3 probably contains two N-glycans sensitive to endoglycosidase H treatment.
The membrane association of TMX3 was demonstrated after subcellular fractionation of HeLa cells. Isolated crude membranes were extracted using sodium carbonate at pH 11.3, and the soluble and insoluble fractions were separated by ultracentrifugation before analyzing the presence of TMX3 in either fraction by Western blotting using anti-TMX3-C. All TMX3 was found in the insoluble fraction exactly like calnexin, an established type I transmembrane protein of the ER (Fig. 3B) . As previously observed, the soluble marker protein, calreticulin, partly fractionated with the insoluble fraction, potentially due 
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to interaction with ER membrane proteins (42) . The ER localization of TMX3, indicated by the presence of endoglycosidase H-sensitive N-glycans, was further investigated by immunofluorescence microscopy on fixed Vero cells. Using the anti-TMX3-C antiserum, we observed a reticular staining pattern typical of the ER (data not shown). However, additional background staining was also observed and remained despite testing a variety of fixation protocols and different dilutions of the antiserum. For exogenously expressed TMX3-HA, the immunostaining showed a clear reticular pattern, and the protein co-localized with a co-expressed ER variant of GFP (Fig. 3C) . We concluded that TMX3 is a membraneassociated, N-glycosylated protein, predominantly localizing to the ER.
Spectroscopic Analysis of Recombinantly Expressed TMX3lum-For in vitro studies of TMX3, we expressed the entire luminal domain (TMX3lum) in E. coli and purified the protein in a two-step procedure involving affinity chromatography followed by anion exchange chromatography. The integrity of the recombinant protein at the sequence level was confirmed by N-terminal sequencing and mass spectrometry.
To assess structural properties of TMX3lum, we used different spectroscopic methods. For a protein with three domains predicted to have a thioredoxin fold, regular secondary structure elements would be expected to be a mixture of ␣-helix and ␤-sheet. Indeed, the far-UV CD spectrum of TMX3lum showed a trace typical of a well structured protein of the ␣/␤-type (Fig.  4A) . Spectra recorded under either reducing or oxidizing conditions differed only very little, indicating that oxidation did not induce any significant conformational change as observed for the PDI a domain, which shows substantial random coil character due to destabilization of the oxidized state (43) .
TMX3lum contains a total of 4 tryptophan and 18 tyrosine residues. To further probe the structural integrity of TMX3lum, we recorded fluorescence emission spectra after excitation at 280 nm (i.e. simultaneous excitation of tryptophan and tyrosine residues) under both native and denaturing conditions (6 M guanidine hydrochloride) (Fig. 4B) . Under the latter conditions, a significant conformational change occurred in the protein giving rise to a shift of the emission maximum from 327 nm (measured for the native protein) to 356 nm and a concomitant decrease in fluorescence intensity. Both changes indicate solvent exposure of tryptophan residues due to protein unfolding. Taken together, the CD and fluorescence spectroscopy measurements showed that our recombinantly expressed TMX3lum displays characteristic features of a folded protein under native conditions.
We also tested the potential influence of the oxidation state of TMX3lum on its fluorescence characteristics. When exciting the protein at 280 nm, we observed a 1.3-fold increase in fluorescence intensity at 327 nm of the reduced state over the oxidized state (Fig. 4B) . The same result was obtained when using an excitation wavelength of 295 nm for the selective excitation of tryptophans (data not shown). Such an intensity difference has also been demonstrated for other thiol-disulfide oxidoreductases such as thioredoxin (44) and ERp57 (45) and is probably due to the quenching of fluorescence of the tryptophan residue (Trp 52 ) located directly before the CGHC motif by the catalytic disulfide bond. The nearly identical traces observed for the reduced and oxidized denatured protein show that the quenched tryptophan residue is no longer influenced by the nearby disulfide bond when the protein is unfolded.
Redox Properties of TMX3-The equilibrium redox potential for a given thiol-disulfide oxidoreductase provides a measure for the propensity of the active site cysteines to be in the reduced or oxidized state. When combined with knowledge about the redox state of the protein in the ER environment and compared with such data obtained for other ER thiol-disulfide oxidoreductases, clues about the enzymatic activity of a given thiol-disulfide oxidoreductase in vivo can potentially be obtained. A human multiple tissue Northern blot was hybridized with a radioactively labeled TMX3 cDNA probe (top panel) and a ␤-actin probe (bottom panel) and visualized by autoradiography. As expected, human ␤-actin, used as a control, shows a 2.0-kb transcript in all tissues and a 1.8-kb isoform in muscle tissues. C, Northern blot analysis after UPR induction and heat shock in HEK293 cells. Total RNA was extracted from untreated HEK293 cells and from cells treated with tunicamycin (10 g/ml, 6 h) or DTT (2 mM, 6 h) or exposed to heat shock (42°C, 30 min) and separated by electrophoresis (upper panel). After transfer to a Zeta-Probe membrane, the extracted RNA was hybridized with 32 Plabeled probes specific for BiP (middle panel) and TMX3 (lower panel) and visualized by autoradiography.
TMX3, a Novel Human PDI Family Member
To determine the redox potential of the TMX3lum construct, we used fluorescence spectroscopy. By taking advantage of the fluorescence intensity difference between oxidized and reduced TMX3lum (Fig. 4B) , the redox equilibrium of the protein was determined based on the fluorescence observed at various GSH/ GSSG ratios. Thus, when incubating TMX3lum in buffers containing 0.1 mM GSSG and concentrations of GSH ranging between 0.015 and 10 mM under the exclusion of oxygen, the fraction of reduced protein was obtained by fitting the experimental results to Equation 1 (see "Materials and Methods") (Fig. 5A) . This method yielded an equilibrium constant for TMX3lum and glutathione of K eq ϭ 1.47 mM. By use of Equations 2 and 3 (the Nernst equation) described under "Materials and Methods," and a value of Ϫ0.240 V for the glutathione standard potential at pH 7.0 and 25°C, the redox potential for TMX3lum was calculated as Ϫ0.157 V.
To ascertain the direct correlation between the fluorescence change observed under different redox conditions and the oxidation state of TMX3lum, we investigated the redox state of TMX3lum by SDS-PAGE analysis after AMS modification (Fig.  5A, inset) . Since AMS adds 450 Da for each free cysteine modified, this method provides a direct visualization of the fraction of reduced protein in any given sample as a result of a mobility shift, corresponding to 900 Da in the case of TMX3lum, when compared with the oxidized protein. Indeed, as expected for the sample equilibrated under buffer conditions close to K eq , we observed a distribution of oxidized to reduced TMX3lum of ϳ1:1.
Next, we wanted to establish the redox state of the TMX3 active site cysteines in mammalian tissue culture cells. To isolate active site cysteines in their native redox state (i.e. to prevent them from engaging in thiol-disulfide exchange reac- 4 and 6 -8) . Finally, the extracts were resolved by SDS-PAGE and subjected to Western blot analysis (WB). Lysates from cells pretreated with DTT or diamide were used as markers for the completely oxidized and reduced state of the protein (arrowheads).
tions during or after cell lysis), we used two different strategies. In one, we lysed cells in 2% SDS and 20% formic acid to protonate, and thereby quench, the reactivity of thiolate anions. After trichloroacetic acid precipitation, free cysteines were modified with AMS. This method is analogous to the one used in Fig. 5A , and therefore reduced TMX3 runs slower than the oxidized form of the protein upon separation by SDS-PAGE (Fig. 5B, compare lanes 3 and 4) . In the second method, living cells were incubated with the cell-permeable alkylating agent NEM to block free cysteines before cell lysis. Subsequently, cell lysates were treated with DTT under denaturing conditions to reduce the disulfide bonds protected from NEM alkylation, prior to trichloroacetic acid precipitation and AMS treatment. By this method, only cysteines present in the disulfide form in vivo are modified by AMS, and therefore oxidized TMX3 runs slower than the reduced form of the protein (Fig. 5B, compare  lanes 7 and 8) .
Western blot analysis was used to evaluate the outcome of both methods. Control samples were generated by incubating cells under reducing conditions using DTT (10 mM) or under oxidizing conditions with diamide (5 mM) prior to lysis under acidic conditions or treatment with NEM. As shown in Fig. 5B  (lanes 2 and 6) , the redox state of TMX3 was predominantly reduced, but with a significant fraction of the protein in the oxidized form. Similar results were obtained irrespective of the method used. Likewise, the distribution of oxidized and reduced TMX3 was found to be comparable in HEK293 and HeLa cells.
Oxidase Activity of TMX3lum-The catalytic activity of TMX3lum was investigated by its ability to oxidize a model decapeptide containing two cysteine residues. As shown in the original application of this method, the formation of an intrachain disulfide quenches the intrinsic fluorescence of the single tryptophan residue present in this peptide to 81% of the value of the reduced form (34) . Here, we added 0.2 M TMX3lum to 3.4 M of the reduced peptide in a buffer containing 2 mM GSH and 0.5 mM GSSG at pH 7.0 and followed the kinetics of oxidation by fluorescence spectroscopy (Fig. 6, curve A) . For comparison, we followed the oxidation catalyzed by PDI (Fig. 6,  curve B ) and the uncatalyzed reaction (Fig. 6, curve C) . The results clearly demonstrate that TMX3lum catalyzes oxidation of the model peptide, although significantly slower than PDI.
A recent comparative study using this assay for a number of ER oxidoreductases, including recombinant human PDI, revealed that for the enzymes tested neither peptide oxidation nor enzyme reoxidation by GSSG was the sole rate-limiting step. 2 The same result was observed for TMX3lum. When performing the assay in the presence of twice the concentration of GSSG, the half-time for oxidation was reduced ϳ1.5-fold. However, if active site reoxidation was the rate-limiting step, a 2-fold reduction in the half-time would have been expected. If, on the other hand, peptide oxidation was rate-limiting, the half-time should not have been influenced by the GSSG concentration. In view of this result, no attempts were made to fit the experimental data for the TMX3lum-and PDI-catalyzed reactions to obtain an initial rate, and instead we determined the half-time for oxidation to provide a measure of oxidase activity. For the representative experiment depicted in Fig. 6 , this analysis showed half-time values of 267 s for TMX3lum, 80 s for PDI, and 751 s for the uncatalyzed reaction.
DISCUSSION
The identification of a previously uncharacterized ER protein with homology to thioredoxin and showing thiol oxidase activity adds a new member to the PDI family. Although PDI itself remains the best characterized protein of this family, the function of, in particular, ERp57 (35, (45) (46) (47) (48) (49) (50) has now also been thoroughly investigated. In recent years, with an increasing number of sequences listed in public data bases, a variety of new PDI family members have been described in the literature. Still, we are far from understanding the function of most of these proteins.
The TMX3 sequence contains a CGHC active site sequence identical to the sequence found in most catalytic thioredoxinlike domains of PDI family members (19) . Other residues important for thiol-disulfide exchange reactivity are also conserved in the thioredoxin-like domain of TMX3, such as an arginine residue (Arg 117 ) proposed to influence the pK a of the active site cysteines (51) and a charge pair (Asp 47 -Lys 81 ) known to be involved in proton transfer reactions in thioredoxin (52) . Therefore, we expected TMX3 to catalyze disulfide bond formation, a prediction supported by the results of the oxidase assay (Fig. 6) . Although clearly faster than the uncatalyzed reaction, peptide oxidation by TMX3 was significantly slower than catalysis by PDI. Whereas the half-time values determined from independent experiments varied somewhat, good qualitative agreement between separate experiments was always observed. Since the determination of the half-time does not rely on the entire data set (34), part of the variation could arise from the method used for data analysis. The relatively slow rate of oxidation by TMX3 can at least to a certain extent be explained by the difference in the number of active sites between the two enzymes (two in PDI, one in TMX3). The other factors that determine the exact rate of peptide oxidation by TMX3 in this assay presently remain unclear.
Efficient isomerization by proteins of the PDI family seems to require the capability to bind substrates directly through a b domain, as seen for PDI, or the direct exposure of the substrate by an interaction partner the way ERp57 is presented to its glycoprotein substrates by the lectin chaperones calnexin and calreticulin (19) . Although TMX3 lacks a typical b domain, the C-terminal two-thirds of the luminal domain 2 L. W. Ruddock, personal communication.
FIG. 6. Catalysis of peptide oxidation by TMX3lum and PDI.
The three curves show the time-dependent fluorescence change of the peptide NRCSQGSCWN observed upon oxidation. Data were recorded at 350 nm after excitation at 280 nm. The normalized peptide fluorescence given on the ordinate was obtained by normalizing to the value of the fully reduced peptide after subtraction of the protein fluorescence (over the course of the experiment, the loss of protein fluorescence was Ͻ1% for both TMX3 and PDI and was therefore neglected in the analysis). The reaction was performed in 100 mM KH 2 PO 4 /KOH, pH 7.0, 2 mM EDTA, 2 mM GSH, and 0.5 mM GSSG with 3.4 M peptide substrate, and oxidation was catalyzed by 0.2 M TMX3lum (curve A) or 0.2 M PDI (curve B) and compared with the uncatalyzed reaction (curve C). The half-time for oxidation was determined to be 267 s for TMX3lum, 80 s for PDI and 751 s for the uncatalyzed reaction. Only in the case of the uncatalyzed reaction was the exponential fit shown as a solid line used to derive the half-time. The corresponding values for TMX3 and PDI were obtained as described in Ref. 34. could still function to recruit a partner protein or in direct substrate interaction.
The broad species and tissue distribution of TMX3 predicts a central and conserved role of the protein. However, RNA interference experiments for the C. elegans gene (ZK973.11) listed on the Wormbase Web site (www.wormbase.org) show no obvious phenotype. Currently, we are investigating whether knockdown of the TMX3 gene in C. elegans leads to increased sensitivity toward stress that induces the UPR. Our finding that TMX3 itself is not up-regulated by the UPR could indicate that the protein has restricted substrate specificity when compared with important general folding catalysts such as BiP and PDI. With close to 20 human PDI family members, it would not be surprising if certain of these, in analogy to the many specialized molecular chaperones of the ER, have specific substrates.
By far most of the proteins in the PDI family are soluble proteins of the ER lumen. Among the transmembrane-bound proteins of this family, TMX2 is only poorly characterized, and its SXXC active site sequence indicates that the protein does not play a role as a thiol-disulfide oxidoreductase (53) . TMX has a rather unusual GPAC active site motif, shows thiol-disulfide exchange reactivity in vitro, and can suppress brefeldin A-induced apoptosis (54, 55) . In C. elegans, the TMX ortholog called DPY-11 localizes to the hypodermis and is important for body and sensory organ morphogenesis potentially by playing a role in collagen maturation (56) . When comparing these data and including our findings for TMX3, no clear functional feature(s) emerges to distinguish the transmembrane-bound from the soluble proteins of the PDI family. Whereas a specific function of the TMX proteins as a group is not obvious, they could preferentially interact with other transmembrane proteins and therefore have a different set of substrates than the soluble family members.
Here we determined the redox potential of TMX3 to be Ϫ0.157 V. Redox potentials for other human PDI family members have previously been measured for ERp57 a, ERp57 a, and PDI, and all show very similar values (Ϫ0.167, Ϫ0.156, and Ϫ0.175 V, respectively) (45, 57) . These values are neither particularly oxidizing nor reducing; for instance, the periplasmic bacterial oxidase DsbA shows a value of Ϫ0.122 V (58), and thioredoxin from E. coli has a redox potential of Ϫ0.270 V (see, for instance, Ref. 59 ).
The relatively moderate and similar values of the redox potentials found so far for ER thiol-disulfide oxidoreductases indicates a common basic mechanism for regulating their redox state. As suggested to be the case for a number of PDI family members, GSH could directly reduce active site cysteines, whereas Ero1 could be the central component of an oxidative pathway (16, 18) . PDI is the only known substrate of Ero1 in mammalian cells, and under steady state conditions, a fraction of PDI molecules are found in the oxidized form (16, 60) . On the other hand, ERp57 and other ER oxidoreductases have been reported to be present almost exclusively in the reduced state (16, 18, 60, 61) . For ERp57, Ero1 overexpression does not seem to shift its redox state toward the oxidized form as seen in the case of PDI (16, 60) , and it is possible that ERp57 functions exclusively as a reductase or an isomerase.
Detailed investigations of oxidative protein folding in vitro have illustrated the difficulties in trapping partially oxidized folding intermediates without perturbing the folding pathway (62) . Whereas the trapping of active site cysteines in thioldisulfide oxidoreductases might be technically less challenging, having to do so in living cells introduces the risk of experimental artifacts arising from disulfide exchange occurring during or after cell lysis. To better ensure the reliability of the results obtained, we used two different methods to trap active site cysteines. We also performed the experiment in both HEK and HeLa cells to investigate potential cell type-specific differences. We consistently found that TMX3 was present predominantly in the reduced form, but with a significant fraction of the protein in the oxidized form. Considering the very similar redox potentials of TMX3 and ERp57 and that the overall redox conditions experienced by the two proteins in the lumen of the ER are probably the same, the finding that TMX3 is partially oxidized in human tissue culture cells suggests the protein to be a substrate of Ero1 or another as yet uncharacterized ER oxidase. Thus, one particular function of TMX3 could be the oxidation of substrates that are not recognized by PDI. Important aims of our future work will be the identification of endogenous substrates for TMX3 and of a potential ER oxidase for the protein.
